Literature DB >> 28183429

Successful facial artery pseudoaneurysm coiling and pedicle preservation following free tissue transfer.

Andrew T Day1, Dane J Genther1, Ferdinand Hui2, Wojciech K Mydlarz1, Gillian Griffith2, Shaun C Desai3.   

Abstract

Patients undergoing free tissue reconstruction are at risk for development of an anastomotic pseudoaneurysm, which may present as delayed neck hemorrhage or a pulsatile neck mass. Diagnosis may be achieved by noninvasive imaging, angiography, and exploration. Management strategies for head and neck pseudoaneurysms have included open vessel ligation, open direct vessel repair, endovascular parent vessel embolization, and, most recently, endovascular pseudoaneurysm embolization. In patients with anastomotic pseudoaneurysms where adequate flap inosculation is doubted, endovascular pseudoaneurysm embolization with pedicle preservation may be an appropriate primary treatment approach. We discuss the successful endovascular coiling of an external carotid artery branch anastomotic pseudoaneurysm in a patient one month after free tissue reconstruction of a total laryngopharyngectomy and partial glossectomy defect.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 28183429     DOI: 10.1016/j.amjoto.2016.09.017

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  3 in total

1.  Excision of true facial artery aneurysm using facial nerve monitoring.

Authors:  Aoife C Kiernan; John Kinsella; Sean Tierney
Journal:  J Vasc Surg Cases Innov Tech       Date:  2018-04-27

2.  The Presentation and Management of Facial Artery Pseudoaneurysm: A Review of the Literature.

Authors:  Suparna Roy; Neha Jain
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-03-26

3.  Profound facial bleeding after buccal mucosa graft harvest - A rare case of facial artery pseudoaneurysm.

Authors:  Johnathan Drevik; Jeffrey L Ellis; Daniel Swerdloff; Andrew Higgins; Jay Simhan
Journal:  Urol Case Rep       Date:  2022-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.